Smoking does increase the risk of breast cancer, though the increase is modest compared to its effect on lung or bladder cancer. Across large pooled analyses, women who have ever smoked face roughly a 7 to 14 percent higher risk of developing invasive breast cancer than women who have never smoked. That relatively small number, combined with decades of confusion about whether alcohol was doing all the statistical heavy lifting, kept smoking off the official list of breast cancer risk factors for years. The relationship turns out to be real, dose-dependent, and shaped by when in life a woman smokes, what her genetic makeup looks like, and which type of breast cancer you measure.
How Large Is the Risk, and How Confident Are We
The numbers from individual studies cluster in a fairly narrow band. A pooled analysis of 14 cohort studies found that current smokers had a hazard ratio of about 1.07 compared to never-smokers after adjusting for alcohol intake, with dose-response trends across cigarettes per day and duration of smoking that were statistically significant but within a tight range of values.
A large UK cohort of over 100,000 women followed for an average of nearly eight years reported a somewhat higher figure: ever-smokers had a 14 percent increase in breast cancer risk. Women who started smoking before age 17 showed a 24 percent increase, and those who began within a few years of their first period had a 23 percent increase.1PubMed Central. Smoking and risk of breast cancer in the Generations Study cohort The European EPIC cohort, one of the largest ever assembled for this question, found that current smokers had a 16 percent higher risk and former smokers a 14 percent higher risk compared to women who had never smoked and were not exposed to secondhand smoke.2PubMed. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort
A systematic review and meta-analysis examining dose-response patterns more precisely found that breast cancer risk climbed linearly with smoking intensity: about 12 percent higher at 20 cigarettes per day and 26 percent higher at 40 cigarettes per day. Duration mattered too, with risk rising roughly 5 percent at 20 years of smoking and 11 percent at 40 years.3PubMed Central. Dose-response Relationships Between Cigarette Smoking and Breast Cancer Risk: A Systematic Review and Meta-analysis The dose-response gradient is one of the stronger pieces of evidence that the association is causal rather than a statistical artifact.
Why This Link Was Debated for So Long
For decades, major reviews concluded that smoking had little or no independent effect on breast cancer. The reason was alcohol. Smoking and drinking are tightly correlated in the population, and alcohol is a well-established breast cancer risk factor. When a massive collaborative reanalysis pooled individual data from 53 epidemiological studies, including over 58,000 women with breast cancer, it found that the apparent smoking effect essentially disappeared after accounting for alcohol. Among women who reported drinking no alcohol at all, the relative risk for ever-smokers was just 1.03, and for current smokers it was 0.99.4PubMed Central. Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease That finding was influential enough to stall the conversation for years.
More recent work has pushed back. A study in the Multiethnic Cohort, which included large numbers of women who did not drink, found that various measures of smoking exposure were associated with higher breast cancer risk regardless of whether women consumed alcohol, and that the risk did not differ across racial and ethnic groups.5American Journal of Epidemiology. Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol: The MEC Study The evidence has shifted enough that agencies like the International Agency for Research on Cancer and the U.S. Surgeon General now recognize an association between active smoking and breast cancer risk.
The Biology Behind the Connection
Tobacco smoke contains dozens of known carcinogens, and several of them reach breast tissue. Studies using sensitive laboratory techniques have found DNA adducts — chemical marks left when carcinogens bind to DNA — in breast tissue from smokers. In one early pilot study, a distinctive pattern of adducts associated with tobacco smoke appeared in breast tissue from five of 15 women with breast cancer, all of whom were current smokers; none of the nonsmokers showed that pattern.6PubMed. Carcinogen-DNA adducts in human breast tissue A later study specifically measured DNA adducts from 4-aminobiphenyl, a well-known tobacco carcinogen and bladder cancer cause, and found that adduct levels in normal breast tissue adjacent to tumors tracked with smoking status in a dose-dependent way.7Carcinogenesis. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke
But tobacco does something unusual in the breast. Alongside its carcinogenic compounds, it also has anti-estrogenic properties. Nicotine and other tobacco chemicals interfere with aromatase, an enzyme that converts androgens into estrogens. This means smoking simultaneously promotes cancer through DNA damage and may suppress it by lowering estrogen levels. Before menopause, when estrogen levels are high, the carcinogenic effects appear to dominate. After menopause, when estrogen levels are already low, the anti-estrogenic action of tobacco may partially offset the cancer-promoting effects.8PubMed Central. A possible dual effect of cigarette smoking on the risk of postmenopausal breast cancer When researchers separate premenopausal and postmenopausal smoking in their analyses, they sometimes find that premenopausal smoking raises risk in a dose-dependent way while postmenopausal smoking is inversely associated with risk — a pattern that only becomes visible when you look at the two periods separately.9Tobacco Induced Diseases. Smoking history and breast cancer risk by pathological subtype: MCC-Spain study – Section: DISCUSSION
This dual effect helps explain why the overall association between smoking and breast cancer looks weaker than you might expect from a habit that delivers potent carcinogens directly to breast tissue. The two mechanisms are working against each other, and the net result depends on when and how much a woman smokes.
Why Smoking Young Seems to Matter Most
Breast tissue undergoes a dramatic transformation during and after a first full-term pregnancy. The cells become more differentiated, meaning more specialized and less vulnerable to the kind of DNA damage that can trigger cancer. Before that differentiation happens, breast tissue appears to be more susceptible to carcinogens. This is why multiple studies have found that smoking between puberty and a first pregnancy carries a greater risk than smoking later in life.
One large analysis found a statistically significant 3 percent increase in risk per pack-year of smoking between menarche and first childbirth, with no significant association for smoking after first childbirth. Risk also increased with younger age at smoking initiation, even after adjusting for total pack-years, suggesting the timing of exposure has an effect independent of how much a woman smokes.10American Journal of Epidemiology. Smoking Cigarettes before First Childbirth and Risk of Breast Cancer A meta-analysis that pooled data from studies specifically looking at smoking before a first pregnancy found a summary risk ratio of 1.10, and found no meaningful difference between smoking only before versus only after a first pregnancy, though the authors noted the possibility of residual confounding at that small effect size.11PubMed Central. Smoking before the first pregnancy and the risk of breast cancer: a meta-analysis
For BRCA1 and BRCA2 mutation carriers, the window before first pregnancy also appears important. In a large consortium study, smoking for more than five years before a first full-term pregnancy was associated with a roughly 19 to 25 percent increase in breast cancer risk for both BRCA1 and BRCA2 carriers, even though general smoking measures showed weaker or nonsignificant associations.12PubMed. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium An earlier case-control study in BRCA carriers under 50 found the risk more dramatic: women with five or more pack-years had roughly double the breast cancer risk, with risk climbing about 7 percent per pack-year in both BRCA1 and BRCA2 carriers.13PubMed Central. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years
Secondhand Smoke
If active smoking raises risk, a natural question is whether breathing someone else’s smoke does too. The EPIC cohort found that women who were passively exposed to smoke at home or work at study enrollment had a 10 percent higher risk of breast cancer compared to women who neither smoked nor were exposed to secondhand smoke.2PubMed. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort
A study in the Multiethnic Cohort focused on a more specific question: childhood exposure to secondhand smoke among women who were themselves never-smokers. Postmenopausal women who reported any childhood exposure had a 17 percent higher risk of breast cancer. Among those with the heaviest exposure — three or more hours a day for 18 or more years — the risk was 28 percent higher, with a clear dose-response trend.14PubMed Central. Childhood exposure to second-hand smoke (SHS) and risk of breast cancer in postmenopausal never smokers: the Multiethnic Cohort (MEC) study This finding aligns with the broader pattern that early-life exposure, when breast tissue is less differentiated, may carry outsized consequences.
Genetic Differences in How the Body Handles Tobacco
Not everyone processes tobacco carcinogens the same way. An enzyme called NAT2 helps detoxify aromatic amines, one of the carcinogen classes in tobacco smoke. People inherit different versions of the NAT2 gene, which can be roughly classified as fast or slow acetylators based on how quickly the enzyme works. Slow acetylators clear these carcinogens more slowly, meaning the compounds linger longer and have more opportunity to damage DNA.
A pooled analysis and meta-analysis found a significant interaction between smoking, NAT2 genotype, and breast cancer risk: among women with slow NAT2 genotypes, higher pack-years of smoking were associated with about a 49 percent increase in breast cancer risk.15Cancer Epidemiology, Biomarkers & Prevention. Cigarette Smoking, N-Acetyltransferase 2 Genotypes, and Breast Cancer Risk: Pooled Analysis and Meta-analysis A separate meta-analysis confirmed that while NAT2 genotypes alone do not raise breast cancer risk, the combination of slow NAT2 and heavy smoking history does.16PubMed. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis One population-based study in Hispanic and non-Hispanic white women found an even starker result: non-Hispanic white women with the very slowest acetylator phenotype who smoked had more than double the breast cancer risk of nonsmokers with the same genotype.17PubMed Central. N-acetyltransferase 2 Genotype Modification of Active Cigarette Smoking on Breast Cancer Risk among Hispanic and Non-Hispanic White Women
Most people do not know their NAT2 status, and routine genetic testing for it is not standard practice. But this interaction matters for interpreting the population-level data: the average risk increase from smoking may be modest in part because the population includes fast acetylators for whom the effect is smaller, diluting the signal from the slow acetylators who carry a substantially higher risk.
Which Types of Breast Cancer Are Affected
Breast cancer is not one disease. The major subtypes behave differently and respond to different treatments. Whether smoking favors one subtype over another matters for understanding the mechanism and for individual risk assessment.
The evidence points fairly consistently toward estrogen receptor-positive (ER+) breast cancer as the subtype most strongly linked to smoking. A study of women aged 20 to 44 found that ever-smokers had a 40 percent increased risk of ER+ breast cancer but no elevation in triple-negative disease. Among current or recent smokers with ten or more pack-years, the ER+ risk was 60 percent higher, while triple-negative risk was unchanged.18PubMed Central. Active smoking and risk of estrogen receptor positive and triple-negative breast cancer among women 20–44 years of age Another analysis found that smoking did not alter the risk of triple-negative or HER2-overexpressing breast cancer relative to ER+ cancer.19PubMed Central. Alcohol, smoking, and risk of Her2-overexpressing and triple-negative breast cancer relative to estrogen receptor-positive breast cancer
This pattern makes biological sense given the dual mechanism. If tobacco’s anti-estrogenic effects are partially counteracting its carcinogenic effects, you would expect the carcinogenic signal to show up most clearly in tumors that are themselves driven by estrogen signaling.
Smoking After a Breast Cancer Diagnosis
For women already diagnosed with breast cancer, whether they smoke affects both their breast cancer outcomes and their overall survival. A large study using data from a major cancer registry found that women who were active smokers in the year before their breast cancer diagnosis had a 25 percent higher risk of dying from breast cancer specifically. Women who continued to smoke after diagnosis had a 72 percent higher risk of breast cancer death compared to never-smokers. Those who quit after diagnosis had lower mortality from both breast cancer and respiratory cancers compared to those who kept smoking.20PubMed Central. Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases
Among former smokers specifically, heavier lifetime exposure still carried consequences. A study of former smokers with breast cancer found that those with 20 or more pack-years in their history had a 54 percent increase in breast cancer mortality and an 81 percent increase in overall mortality compared to lighter former smokers.21PubMed Central. Mortality Risk in Former Smokers with Breast Cancer: Pack-years vs. Smoking Status Recurrence after breast-conserving surgery was also significantly higher among current smokers, with one study finding a recurrence rate nearly seven times that of never-smokers after adjusting for race and tumor stage.22PubMed Central. Smoking and Breast Cancer Recurrence after Breast Conservation Therapy
Treatment complications add another layer. A systematic review of smoking’s impact on breast cancer radiation treatment found that smokers had significantly worse outcomes across multiple categories, including skin reactions, cardiovascular complications, reconstruction outcomes, and secondary recurrences. Not a single study in the review found that nonsmokers fared worse than smokers on any outcome.23PubMed. The impact of smoking on adjuvant breast cancer radiation treatment: A systematic review
The Mammographic Density Paradox
Dense breast tissue on a mammogram is one of the strongest known risk factors for breast cancer. You might expect that if smoking raises breast cancer risk, it would also raise breast density. It does the opposite. A prospective study of postmenopausal women from the EPIC Florence cohort found an inverse association between smoking exposure and mammographic density, with a dose-response relationship: more cigarettes, more years of smoking, and more pack-years were all linked to lower density.24PubMed Central. Cigarette smoking and mammographic breast density in post-menopausal women from the EPIC Florence cohort
This is the anti-estrogenic effect of tobacco showing up on imaging. Smoking reduces estrogen activity, which lowers breast density, which should theoretically lower breast cancer risk. But smoking still raises risk through direct carcinogenic damage to breast cell DNA. The fact that smoking decreases a major protective biomarker yet still increases cancer risk underscores that the carcinogenic pathway bypasses the hormonal one entirely. It also means you cannot look at a mammogram and conclude that a smoker’s lower density makes her safer.
E-Cigarettes and Nicotine
If traditional cigarettes increase breast cancer risk partly through combustion-generated carcinogens and partly through nicotine-mediated effects, a natural question is whether e-cigarettes — which deliver nicotine without combustion — carry any breast cancer risk. Human epidemiological data are too scarce to answer this directly, but laboratory studies offer reasons for concern.
Animal experiments have found that nicotine exposure increased lung metastatic burden from breast cancer by over 100-fold in mouse models, far more than it increased primary tumor growth. Nicotine appeared to precondition the lung immune environment in ways that favored metastatic colonization.25Nature Communications. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung Separate studies using e-cigarette vapor specifically found that it promoted breast cancer cell growth and lung metastasis in mice, increased tumor-associated immune cell infiltration, and reduced cancer cell death. In lab dishes, e-cigarette vapor condensate stimulated breast cancer cell migration and activated pro-tumor signaling.26PubMed Central. E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1 Another mouse study found that e-cigarette exposure nearly doubled the tumor burden in the lungs when breast cancer cells were introduced, primarily by reducing tumor cell death rather than increasing proliferation.27PubMed Central. Electronic cigarettes promotes the lung colonization of human breast cancer in NOD-SCID-Gamma mice
These are animal and cell-culture studies, so they cannot tell you how much e-cigarettes would raise breast cancer risk in humans. But they suggest that nicotine alone, even without tobacco combustion products, could promote the spread of breast cancer if it has already developed. For women with a breast cancer diagnosis or at high risk, this is worth considering even though the epidemiological evidence is years away from being definitive.
Epigenetic Fingerprints of Smoking in Breast Tumors
Beyond directly damaging DNA, smoking also changes how genes are read. Researchers studying breast tumor tissue from the Carolina Breast Cancer Study found that tumors from smokers showed distinct patterns of DNA methylation compared to tumors from never-smokers. Hormone receptor-negative tumors from smokers showed primarily reduced methylation, which can activate genes that would normally stay silent. Among former smokers, methylation levels were intermediate between current and never-smokers, and women who had quit for longer periods showed methylation patterns drifting back toward the baseline of someone who never smoked.28PubMed Central. Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study This finding has two implications: smoking leaves a lasting molecular signature in breast tissue, and quitting gradually, though perhaps not completely, reverses that signature. The reversibility reinforces the consistent finding across studies that former smokers have lower breast cancer risk than current smokers, and that the benefit of quitting grows with time.